The results of Phase I demonstrated the feasibility of the TraumaSKINS system concept and indicated that the first TraumaSKINS product should provide an innovative, realistic simulation of a particular type of battlefield injury. Trauma skins will simulate this injury but also provide stimulus elements that simulate the medic environment associated with such injuries. The simulation will be based on special effects technologies and will realistically simulate visual, auditory, haptic and olfactory aspects such that the medic can be desensitized to traumatic injuries in order to perform more effectively and efficiently. In Phase II, a prototype of the TraumaSKINS product will be constructed, evaluated and refined through testing that will involve both developmental testing by our panel of medical experts in military and civilian medical training. Phase II will also involve human factors analysis of the prototype construction process in order to identify specific areas for Phase III manufacturing research and development. TraumaSKINS will interface to a wide variety of human medical simulators. A flexible commercialization plan has been developed for Phase III which features an early first-to-market strategy with continuing technology innovation based on the human factors analysis in Phase II to reduce the cost of manufacture.
Keywords: Trauma, Medic, Training, Simulated Tissue, Simulation, Human Factors, Special Effects